The PE Ratio as of May 2025 (TTM) for Avid Bioservices, Inc. (CDMO) is -5.18

According to Avid Bioservices, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.18. This represents a change of -64.24% compared to the average of -14.49 of the last 4 quarters.

Avid Bioservices, Inc. (CDMO) Historical PE Ratio (quarterly & annually)

How has CDMO PE Ratio performed in the past?

The mean historical PE Ratio of Avid Bioservices, Inc. over the last ten years is 195.80. The current -5.18 PE Ratio has changed -364.69% with respect to the historical average. Over the past ten years (40 quarters), CDMO's PE Ratio was at its highest in in the January 2023 quarter at 535.58. The PE Ratio was at its lowest in in the April 2023 quarter at -899.31.

Avid Bioservices, Inc. (CDMO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Avid Bioservices, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Avid Bioservices, Inc. (CDMO) Average PE Ratio

How has CDMO PE Ratio performed in the past?

The current PE Ratio of Avid Bioservices, Inc. (CDMO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Avid Bioservices, Inc. (CDMO) PE Ratio vs. Peers

How is CDMO’s PE Ratio compared to its peers?

Avid Bioservices, Inc.’s PE Ratio is greater than Anebulo Pharmaceuticals, Inc. (-5.61), less than Adagene Inc. (-3.16), less than Acrivon Therapeutics, Inc. Common Stock (-0.55), less than AnaptysBio, Inc. (-4.43), less than Mineralys Therapeutics, Inc. (-4.40), greater than Crinetics Pharmaceuticals, Inc. (-8.85), greater than Cytokinetics, Incorporated (-6.05), greater than Cerevel Therapeutics Holdings, Inc. (-17.73), less than Bicycle Therapeutics plc (-2.78), greater than Chinook Therapeutics, Inc. (-14.08), greater than Immunocore Holdings plc (-69.29), greater than Mirum Pharmaceuticals, Inc. (-28.60), less than Larimar Therapeutics, Inc. (-1.34), less than KalVista Pharmaceuticals, Inc. (-3.53), less than Lyra Therapeutics, Inc. (-0.10), greater than DICE Therapeutics, Inc. (-22.94), greater than Edgewise Therapeutics, Inc. (-9.61), greater than Karuna Therapeutics, Inc. (-37.08), less than Dyne Therapeutics, Inc. (-3.58), less than IDEAYA Biosciences, Inc. (-5.08), less than MeiraGTx Holdings plc (-2.38), less than Keros Therapeutics, Inc. (133.95), less than Homology Medicines, Inc. (-0.45),

Build a custom stock screener for Avid Bioservices, Inc. (CDMO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avid Bioservices, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Avid Bioservices, Inc. (CDMO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Avid Bioservices, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.